Performance analysis of China Pharma (CPHI)
Annual Return
Over the past 3 years, CPHI has had an average annual return of -57.54%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CPHI has had an average annual return of -66.94%, underperforming the benchmark SPY, which returned +14.05% annual.
Over the past 10 years, CPHI has had an average annual return of -34.63%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Apr 17, 2002, CPHI has had an average annual return of -31.72%, underperforming the benchmark SPY, which returned +10.20% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -50.00% | -50.00% | -87.50% | -80.12% | +8.05% | +86.25% | -6.98% | +43.33% | -31.03% | +67.31% | -48.00% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -13.04% | +71.64% | -69.96% | -77.92% | -21.28% | +237.63% | -62.64% | +34.35% | +26.17% | +351.13% | -86.70% | +25% |
| 2002 | |||||||||||
| -92.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | ||||||||
| 2025 | -50.00% | +0% | +100% | -50.00% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | -50.00% |
| 2024 | -25.00% | -33.33% | +0% | +0% | +0% | +0% | -50.00% | +0% | +100% | +0% | -50.00% | +100% | -50.00% |
| 2023 | +12.50% | -38.89% | -40.91% | -7.69% | -8.33% | -0% | +0% | -54.55% | +0% | -40.00% | +33.33% | +0% | -87.50% |
| 2022 | -14.91% | +6.57% | -10.96% | -28.46% | -17.20% | -6.49% | -1.39% | -8.45% | -33.85% | -2.33% | -4.76% | -20.00% | -80.12% |
| 2021 | +59.06% | +24.89% | -5.41% | -8.21% | -23.35% | +22.34% | +12.03% | -15.19% | -18.78% | +16.13% | -4.17% | -22.22% | +8.05% |
| 2020 | +96.25% | +21.02% | -12.11% | -4.19% | -6.25% | +48.67% | -28.25% | -18.75% | -6.15% | +5.74% | +12.40% | +2.76% | +86.25% |
| 2019 | +12.79% | +0% | +13.40% | -0% | -27.27% | +33.75% | -10.28% | -9.37% | -4.60% | +6.02% | -12.50% | +3.90% | -6.98% |
| 2018 | +83.33% | +15.45% | -15.75% | -15.89% | +0% | -18.89% | +19.18% | -8.05% | -15.00% | +66.18% | -8.85% | -16.50% | +43.33% |
| 2017 | -4.60% | -3.61% | +8.75% | -1.15% | -6.98% | -3.75% | -9.09% | -8.57% | -9.37% | -5.17% | +9.09% | -0% | -31.03% |
Drawdown analysis of China Pharma (CPHI)
The maximum drawdown for the CPHI was -99.99%, occurring on Jul 30, 2024. This drawdown has not yet recovered.
The current CPHI drawdown is -99.99%.
Since Apr 17, 2002 CPHI has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Apr 18, 2002 | 5608 | Jul 30, 2024 | Ongoing | Ongoing | Ongoing |